LOW DISEASE ACTIVITY OR DAS-REMISSION AS TREATMENT TARGET IN EARLY RHEUMATOID ARTHRITIS PATIENTS

被引:0
|
作者
Akdemir, G. [1 ]
Markusse, I. M. [1 ]
Schouffoer, A. A. [2 ]
de Sonnaville, P. B. [3 ]
Grillet, B. A. [4 ]
Kerstens, P. J.
Lems, W. F. [5 ]
Huizinga, T. W. [1 ]
Allaart, C. F. [1 ]
机构
[1] LUMC, Rheumatol, Leiden, Netherlands
[2] Haga Hosp, Rheumatol, The Hague, Netherlands
[3] ADRZ, Rheumatol, Goes, Netherlands
[4] Zorgsaam, Rheumatol, Terneuzen, Netherlands
[5] Vrije Univ Amsterdam Med Ctr, Amsterdam Rheumatol & Immunol Ctr, Rheumatol, Amsterdam, Netherlands
关键词
D O I
10.1136/annrheumdis-2016-eular.2715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0076
引用
收藏
页码:454 / 454
页数:1
相关论文
共 50 条
  • [1] Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis
    Akdemir, Gulsah
    Markusse, Iris M.
    Bergstra, Sytske Anne
    Goekoop, Robbert J.
    Molenaar, Esmeralda T.
    van Groenendael, Johannes H. L. M.
    Kerstens, Pit J. S. M.
    Lems, Willem F.
    Huizinga, Tom W. J.
    Allaart, Cornelia F.
    [J]. RMD OPEN, 2018, 4 (01):
  • [2] Treat to Target, Remission and Low Disease Activity in the Treatment of Rheumatoid Arthritis
    Martin Jan Bergman
    [J]. Current Treatment Options in Rheumatology, 2020, 6 : 260 - 267
  • [3] Treat to Target, Remission and Low Disease Activity in the Treatment of Rheumatoid Arthritis
    Bergman, Martin Jan
    [J]. CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (03) : 260 - 267
  • [4] Treatment Target in a Disease Activity Score Steered Treatment Protocol in Early Arthritis Patients: Low Disease Activity or Remission
    Akdemir, Gulsah
    Markusse, Iris M.
    van Groenendael, Johannes H. L. M.
    Peeters, Andre J.
    Molenaar, Esmeralda T.
    Kerstens, Pit J. S. M.
    Lems, Willem F.
    Huizinga, T. W. J.
    Allaart, Cornelia F.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] The Effect of Treatment Adjustments Aimed at DAS Remission on Physical Functioning in Undifferentiated and Rheumatoid Arthritis Patients in Low Disease Activity
    Bergstra, S. A.
    Vergara, O. M. Olivas
    Akdemir, G.
    Steup-Beekman, G. M.
    Ronday, H. K.
    Harbers, J. B.
    Landewe, R. B. M.
    Allaart, C. F.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] Effects of low-dose etanercept in maintaining DAS-remission previously achieved with standard-dose in patients with rheumatoid arthritis
    Botsios, C.
    Furlan, A.
    Ostuni, R.
    Sfriso, R.
    Todesco, S.
    Punzi, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 54 - 54
  • [7] TREAT TO TARGET EARLY RHEUMATOID ARTHRITIS CLINIC: HIGH RATES OF REMISSION AND LOW DISEASE ACTIVITY ON TREATMENT WITH CONVENTIONAL DISEASE MODIFYING DRUGS
    Semenova, O.
    Thompson, H.
    Kallankara, S.
    Olabambo, O.
    Patel, Y.
    Baguley, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 205 - 206
  • [8] What Is A Realistic Treatment Target in Rheumatoid Arthritis: Remission or Minimal Disease Activity?
    de Punder, Yvonne M. R.
    Fransen, Jaap
    Kievit, Wietske
    Houtman, Pieternella
    Visser, Henk
    van de Laar, Mart A. F. J.
    van Riel, Piet L. C.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S128 - S128
  • [9] APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS
    Bessette, Louis
    Keystone, Ed
    Rahman, Proton
    Anderson, Keltie
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    [J]. INTERNAL MEDICINE JOURNAL, 2020, 50 : 9 - 9
  • [10] APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS
    Bessette, Louis
    Keystone, Edward
    Rahman, Proton
    Anderson, Keltie
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 27 - 27